Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections

Author： Nau R.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.35, Iss.3, 1998-09, pp. : 223-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Central Nervous System Tuberculosis Infections and Neurological Complications of Tuberculosis Treatment

By  

Current Pharmaceutical Design, Vol. 17, Iss. 27, 2011-09 ,pp. : 2940-2947

Bentham Science Publishers

Access to resources Recommend Favorite

Sulfonamide Agents for Treatment of Staphylococcus MRSA and MSSA Infections of the Central Nervous System

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 10, Iss. 1, 2010-03 ,pp. : 84-90

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculosis Infections of the Central Nervous System

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 4, 2011-12 ,pp. : 321-327

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculostatic Drugs Targeting Infections of the Central Nervous System

By Bartzatt Ronald  

Anti-Infective Agents, Vol. 10, Iss. 2, 2012-07 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculostatic Drugs Targeting Infections of the Central Nervous System

By  

Anti-Infective Agents, Vol. 10, Iss. 2, 2012-07 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite